Neurona Therapeutics, a pioneering biotherapeutics company dedicated to innovative neural cell therapies, has successfully secured $120 million in its latest funding round. This impressive capital will be instrumental in accelerating the company's mission of developing single-dose curative treatments for chronic neurological disorders, a critical need that affects millions of individuals globally. With a proprietary platform founded on a novel neural cell lineage, Neurona is at the forefront of advanced regenerative medicine, creating transformative therapies that target neuronal and glial cell dysfunction. The funds will not only enhance the development of Neurona鈥檚 advanced pipeline of neuronal, glial, and gene-edited cell therapy candidates but will also bolster clinical trials aimed at delivering effective long-term repairs to compromised neural networks. This is a significant leap forward for patients suffering from chronic conditions, as Neurona's therapies promise to offer hope where conventional treatments have fallen short. With this influx of finances, the company aims to refine its cutting-edge cell therapy technologies and expand its research initiatives, ultimately driving groundbreaking solutions for some of the most pressing challenges in neurology today. As Neurona continues to advance its vision of a world where neurological disorders can be treated effectively, this funding stands as a testament to the potential impact these therapies could have on countless lives. For more insights into Neurona's innovative approaches and to track their progress, please visit their website.
Neurona Therapeutics Secures $120 Million in Funding to Revolutionize Neurological Disorder Treatment
Recently funded 路 $120.0MBiotherapeutics
Get the full Neurona Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
